Suppr超能文献

[β受体阻滞剂与利尿剂固定复方制剂治疗老年高血压患者的疗效]

[Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients].

作者信息

Paciaroni E, Quattrini L, Saccomanno G, Andreoni A

出版信息

G Ital Cardiol. 1980;10(12):1737-41.

PMID:6114010
Abstract

The antihypertensive activity and tolerability of oxprenolol 80 mg plus chlorthalidone 10 mg in fixed combination were evaluated in 15 hypertensive patients aged more than 60 years (group 1) and, comparatively, in 11 hypertensive patients aged below 60 years (group 2), all with a lying B.P. value greater than 160/100 mmHg at the end of a two weeks placebo wash-out. Lying and standing systolic and diastolic B.P. decreased (P less than 0.001) (lying position: group 1, from 181.0/103.0 to 159.6/87.5 mmHg; group 2, from 173.6/105.4 to 143.3/86.1 mmHg); decrements in group 1 were minor than those in group 2. A diastolic blood pressure normalization was achieved in 12/15 patients of group 1 and in 10/11 of group 2. Side-effects were rare and of mild severity. Results obtained show that the fixed combination oxprenolol 80 mg plus chlorthalidone 10 mg can be safely administered also in the elderly hypertensive patients, without risk of cardiovascular complications, allowing satisfactory blood pressure control, with a simple dosage schedule, thus improving patient compliance to the therapy.

摘要

对15名60岁以上的高血压患者(第1组)以及相对照的11名60岁以下的高血压患者(第2组),评估了80毫克氧烯洛尔与10毫克氯噻酮固定复方制剂的降压活性和耐受性。所有患者在经过两周的安慰剂洗脱期后,卧位血压值均高于160/100 mmHg。卧位和立位的收缩压和舒张压均下降(P<0.001)(卧位:第1组,从181.0/103.0 mmHg降至159.6/87.5 mmHg;第2组,从173.6/105.4 mmHg降至143.3/86.1 mmHg);第1组的降幅小于第2组。第1组15名患者中有12名、第2组11名患者中有10名实现了舒张压正常化。副作用罕见且程度轻微。所得结果表明,80毫克氧烯洛尔与10毫克氯噻酮的固定复方制剂也可安全地用于老年高血压患者,无心血管并发症风险,能实现令人满意的血压控制,给药方案简单,从而提高患者对治疗的依从性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验